Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-1642

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-1642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351642)

Label for Venlafaxine ER 150 mg extended-release capsule packaged by Bryant Ranch Prepack, Burbank, CA. The capsule is described as opaque dark orange, identified as Capsule E 89. The label includes storage instructions at 20°-25°C (68°-77°F), a barcode, and an NDC number 71335-1642-1. It notes comparison to Effexor XR 150mg capsule by Aurobindo Pharma Limited and indicates prescription use only.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A chart showing pharmacokinetic fold changes and 90% confidence interval recommendations for venlafaxine hydrochloride when co-administered with various interacting drugs. The chart plots changes in Cmax and AUC relative to reference values for ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium, alongside dosing or cautionary advice for each interaction.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A chart titled 'Interacting Drug' illustrating pharmacokinetic (PK) fold change and 90% confidence interval recommendations for various drugs interacting with venlafaxine hydrochloride. The chart lists interacting drugs on the left, analytes, PK parameters (Cmax and AUC), and offers guidance like 'No dose adjustment,' 'Use with caution,' or 'Clinical significance unknown.' The horizontal axis represents fold changes relative to a reference value from 0 to 3.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A pharmacokinetic chart illustrating the fold change and 90% confidence intervals (CI) for venlafaxine and its metabolite ODV in special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60 years, and gender. The chart presents Cmax and AUC values with dosing recommendations based on the changes observed relative to the reference value.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride shown as a 2D molecular diagram with atom labels including nitrogen and oxygen, and structural rings representing the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.